These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2886718)

  • 21. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.
    Bottazzo GF; Pujol-Borrell R; Hanafusa T; Feldmann M
    Lancet; 1983 Nov; 2(8359):1115-9. PubMed ID: 6138647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics and regulation of the human immune response. Report on a symposium held at Ringberg Castle, Rottach-Egern a. Tegernsee.
    Corrigan CJ
    Clin Exp Allergy; 1992 Sep; 22(9):869-75. PubMed ID: 1358416
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure and function of the major histocompatibility complex in domestic animals.
    Antczak DF
    J Am Vet Med Assoc; 1982 Nov; 181(10):1030-6. PubMed ID: 6816772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontogeny of MHC-linked, T cell-mediated suppression is regulated by the T cell genotype.
    Araneo BA
    J Mol Cell Immunol; 1986; 2(4):219-31. PubMed ID: 2855403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genetic lesions of autoimmunity.
    Rose NR; Kong YC; Sundick RS
    Clin Exp Immunol; 1980 Mar; 39(3):545-50. PubMed ID: 6769621
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of the MHC in autoimmunity: an overview.
    Mellins ED
    J Rheumatol Suppl; 1992 Apr; 33():63-9. PubMed ID: 1593605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1987 Philip Levine award lecture. MHC haplotypes in biology and medicine.
    Yunis EJ
    Am J Clin Pathol; 1988 Feb; 89(2):268-80. PubMed ID: 2963535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major histocompatibility complex antigen expression on lymphocytes from aging strain A mice.
    Janick-Buckner D; Briggs CJ; Meyer TE; Harvey N; Warner CM
    Growth Dev Aging; 1991; 55(1):53-62. PubMed ID: 1864685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-response gene-associated antigens (Ia/DR). Structure and function in immunologically related diseases.
    Gorzynski TJ; David CS
    Mayo Clin Proc; 1983 Jul; 58(7):457-66. PubMed ID: 6408318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice.
    Sidman CL; Luther EA; Marshall JD; Nguyen KA; Roopenian DC; Worthen SM
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7624-8. PubMed ID: 3313400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenetic aspects of host immune response.
    Inman RD
    Can J Microbiol; 1988 Mar; 34(3):319-22. PubMed ID: 3046724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious diseases and immunity: special reference to major histocompatibility complex.
    Singh N; Agrawal S; Rastogi AK
    Emerg Infect Dis; 1997; 3(1):41-9. PubMed ID: 9126443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The HLA histocompatibility system].
    Wadgymar A
    Rev Invest Clin; 1984; 36(3):287-92. PubMed ID: 6393263
    [No Abstract]   [Full Text] [Related]  

  • 40. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease.
    Baum H; Staines NA
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):115-25. PubMed ID: 9287250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.